mod 3 - cns depressants and opiods Flashcards
what are sedative hyponotic agents
CNS depressants
what are the magnitudes of CNS depressants
low to high dose:
1. anti-anxiety
2. sedation
3. hypnosis (sleep)
4. general anesthesia
mechanism of action of sedative hypnotics
without s/h:
- more excitatory than inhibitory input causing neurons to fire
- excitatory input releases glutamate
with s/h:
- inhibitory signals from GABA neurons increase
- decreases glutamate nerve firing
GABA signalling
GABA: primary inhibitory neurotrasnmitter
- modifies chloride channels and allow an influx of sodium ions
- causing it harder for the postsynaptic neuron to transmit incoming messages to other neurons
- depressing CNS signallling
drugs that bind to the chloride channel
- benzodiazepines
- barbiturates
- benzodiazepine-like drugs
- alcohol
benzodiazepines
- among most widely prescribed drugs in the world (5-10% Canadians)
benzodiazepine route of administration
capsule or tablet
- some avail for intravenous or intranasal use
benzodiazepines mechanism of action
- activating benzodiazepine receptor inc FREQUENCY of chloride channel openings
benzodiazepines therapeutic effects
- relaxation, calmness, relief from anxiety or tension
- skeletal muscle relaxation
- anticonvulsant effects
- MINIMAL suppression of REM-type sleep (effective hypnotic)
lethality of benzodiazepines
- one of the most commonly involved in overdose
- high therapeutic index – wide margin of safety, overdoses are rare
- ingestion of enormous dose, iv injection of large dose, or in combination with other sedating drugs = death
antidote for benzodiazepines
flumazenil
adverse effects of benzodiazepine use
short term
- CNS: drowsiness, lethargy, fatigue, impaired thinking and memory
- breathing: respiratory depression
- motor coordination: impair motor and driving
long term
- varies
benzodiazepines in special populations
pregnant/breastfeeding:
- cross placenta and distribute into the fetus
- first trimester: small but significant risk for fetal abnormalities
- secreted into the milk, exposes nursing infants – may result in sedation or death
older adults:
- cognitive dysfunction
- metabolized slower often leading to over-sedation, falls, injury
benzodiazepines potential for misuse and SUD
misuse: low
- weaker natural drug properties
- low inherent harm
tolereance: yes, develops to desired effects but not a clinical issue
- develops to sedative effects and impairment of coordination, anxiolytic effects (less common), euphoria (occasionally)
- cross tolerance: with other s-h drugs like barbiturates and alcohol
withdrawal: yes, less common
- mild
- anxiety, headache, insomnia
addiction: yes, in some
- sometimes
barbiturates duration of action
- long acting (1-2 days)
- short acting (3-8 hours)
- untra short acting (20 minutes)
barbiturates routes of administration
- varies
- epilepsy: orally
- anesthesia: intravenosuly
barbiturates mechanism of action
- inc DURATION of opening of chloride channel
- demonstrate full spectrum of dose-dependent CNS depression (anti anxiety, sedation, hypnosis, anesthesia, death)
barbiturates therapeutic uses
low dose: tranquility and relaxation, induce sleep
- limited clinical use
- ultra-short and short-acting induce anesthesia
- long-acting: antiepileptics
barbiturates lethality
- most have been replaced for newer and safer drugs
- have a low therapeutic index
- no antidote
- withdrawal can cause death
adverse effects of barbiturates
short term
- low dose: mild euphoria and reduced interest
- dizzy and impairment of motor coordination
- pleasurable state of intoxication and euphoria when dose increased
- high dose: depress cardio system, slow heart and lower bp
long term
- chronic inebriation
- memory, judment, thinking impairment
- hostility
- mood swings and depression
barbiturates potential for misuse and SUD
misuse: equal or greater than alcohol (mod)
- significant pleasurable effects
- injected for a “rush effect”
- inherent harm is very high – can die from respiratory depression or withdrawal
tolerance: yes
- cross tolerance between other sedatives
withdrawal: yes
- tremors, anxiety, weakness, insomnia, postural hypotension (low bp, bp drops when sudden standing up)
- progress to seizures, delirium, visual hallucinations , high body temp
- withdrawal must occur slowly under medical supervision
addiction: yes
- large cravings irrespective of the dose
benzodiazepine-like drugs
- zopiclone
- zolpidem
- treat anxiety and insomnia
- bind to a subset of GABA receptors and cause sedation
- disturb sleep patterns (REM sleep) even less than benzos
- more sedative than anxiolytic effects
- inc freq of chloride channel opening
difference between benzo and barbit receptor binding
benzos: bind to GABA, inc frequency of chloride channel opening
barb: bind to GABAA, inc duration of chloride channel opening
therapeutic uses of sedative-hypnotics
barbiturates: anit-epileptic
benzos: anti-anxiety
benzo-like-drugs: hypnotic
flumazenil: antidote for benzo